BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29950170)

  • 1. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.
    Milko LV; Rini C; Lewis MA; Butterfield RM; Lin FC; Paquin RS; Powell BC; Roche MI; Souris KJ; Bailey DB; Berg JS; Powell CM
    Trials; 2018 Jun; 19(1):344. PubMed ID: 29950170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental Views on Newborn Next Generation Sequencing: Implications for Decision Support.
    Moultrie RR; Paquin R; Rini C; Roche MI; Berg JS; Powell CM; Lewis MA
    Matern Child Health J; 2020 Jul; 24(7):856-864. PubMed ID: 32424581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn Screening.
    Milko LV; O'Daniel JM; DeCristo DM; Crowley SB; Foreman AKM; Wallace KE; Mollison LF; Strande NT; Girnary ZS; Boshe LJ; Aylsworth AS; Gucsavas-Calikoglu M; Frazier DM; Vora NL; Roche MI; Powell BC; Powell CM; Berg JS
    J Pediatr; 2019 Jun; 209():68-76. PubMed ID: 30851990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid.
    Lewis MA; Paquin RS; Roche MI; Furberg RD; Rini C; Berg JS; Powell CM; Bailey DB
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S16-23. PubMed ID: 26729698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parental Attitudes Toward Standard Newborn Screening and Newborn Genomic Sequencing: Findings From the BabySeq Study.
    Armstrong B; Christensen KD; Genetti CA; Parad RB; Robinson JO; Blout Zawatsky CL; Zettler B; Beggs AH; Holm IA; Green RC; McGuire AL; Smith HS; Pereira S;
    Front Genet; 2022; 13():867371. PubMed ID: 35571041
    [No Abstract]   [Full Text] [Related]  

  • 6. Genomic Sequencing for Newborn Screening: Results of the NC NEXUS Project.
    Roman TS; Crowley SB; Roche MI; Foreman AKM; O'Daniel JM; Seifert BA; Lee K; Brandt A; Gustafson C; DeCristo DM; Strande NT; Ramkissoon L; Milko LV; Owen P; Roy S; Xiong M; Paquin RS; Butterfield RM; Lewis MA; Souris KJ; Bailey DB; Rini C; Booker JK; Powell BC; Weck KE; Powell CM; Berg JS
    Am J Hum Genet; 2020 Oct; 107(4):596-611. PubMed ID: 32853555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial Effect of Newborn Genomic Sequencing on Families in the BabySeq Project: A Randomized Clinical Trial.
    Pereira S; Smith HS; Frankel LA; Christensen KD; Islam R; Robinson JO; Genetti CA; Blout Zawatsky CL; Zettler B; Parad RB; Waisbren SE; Beggs AH; Green RC; Holm IA; McGuire AL;
    JAMA Pediatr; 2021 Nov; 175(11):1132-1141. PubMed ID: 34424265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental Views on Expanded Newborn Screening Using Whole-Genome Sequencing.
    Joseph G; Chen F; Harris-Wai J; Puck JM; Young C; Koenig BA
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S36-46. PubMed ID: 26729702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective Study of Parental Perceptions of Rapid Whole-Genome and -Exome Sequencing among Seriously Ill Infants.
    Cakici JA; Dimmock DP; Caylor SA; Gaughran M; Clarke C; Triplett C; Clark MM; Kingsmore SF; Bloss CS
    Am J Hum Genet; 2020 Nov; 107(5):953-962. PubMed ID: 33157008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
    Staley BS; Milko LV; Waltz M; Griesemer I; Mollison L; Grant TL; Farnan L; Roche M; Navas A; Lightfoot A; Foreman AKM; O'Daniel JM; O'Neill SC; Lin FC; Roman TS; Brandt A; Powell BC; Rini C; Berg JS; Bensen JT
    Trials; 2021 Jun; 22(1):395. PubMed ID: 34127041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into National Laboratory Newborn Screening and Future Prospects.
    Mujamammi AH
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of information about newborn screening antenatally: a sequential exploratory mixed-methods project.
    Ulph F; Wright S; Dharni N; Payne K; Bennett R; Roberts S; Walshe K; Lavender T
    Health Technol Assess; 2017 Oct; 21(55):1-240. PubMed ID: 28967862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consent for newborn screening: parents' and health-care professionals' experiences of consent in practice.
    Etchegary H; Nicholls SG; Tessier L; Simmonds C; Potter BK; Brehaut JC; Pullman D; Hayeems R; Zelenietz S; Lamoureux M; Milburn J; Turner L; Chakraborty P; Wilson B
    Eur J Hum Genet; 2016 Nov; 24(11):1530-1534. PubMed ID: 27302842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Education of Parents About Newborn Screening and Residual Dried Blood Spots: A Randomized Clinical Trial.
    Botkin JR; Rothwell E; Anderson RA; Rose NC; Dolan SM; Kuppermann M; Stark LA; Goldenberg A; Wong B
    JAMA Pediatr; 2016 Jun; 170(6):543-9. PubMed ID: 27043416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that influence parental decisions to participate in clinical research: consenters vs nonconsenters.
    Hoberman A; Shaikh N; Bhatnagar S; Haralam MA; Kearney DH; Colborn DK; Kienholz ML; Wang L; Bunker CH; Keren R; Carpenter MA; Greenfield SP; Pohl HG; Mathews R; Moxey-Mims M; Chesney RW
    JAMA Pediatr; 2013 Jun; 167(6):561-6. PubMed ID: 23546617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing as a follow-up test in an expanded newborn screening programme.
    Smon A; Repic Lampret B; Groselj U; Zerjav Tansek M; Kovac J; Perko D; Bertok S; Battelino T; Trebusak Podkrajsek K
    Clin Biochem; 2018 Feb; 52():48-55. PubMed ID: 29111448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased parental anxiety and a benign clinical course: Infants identified with short-chain acyl-CoA dehydrogenase deficiency and isobutyryl-CoA dehydrogenase deficiency through newborn screening in Georgia.
    Sadat R; Hall PL; Wittenauer AL; Vengoechea ED; Park K; Hagar AF; Singh R; Moore RH; Gambello MJ
    Mol Genet Metab; 2020 Jan; 129(1):20-25. PubMed ID: 31813752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parents' attitudes toward pediatric genetic testing for common disease risk.
    Tercyak KP; Hensley Alford S; Emmons KM; Lipkus IM; Wilfond BS; McBride CM
    Pediatrics; 2011 May; 127(5):e1288-95. PubMed ID: 21502235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.